Molecular genetic background of haemophilia A patients with discrepancy between one-stage and two-stage factor VIII assays

A. Pavlova; D. Delev; S. Pahl; J. Driesen; H. Brondke; J. Oldenburg

doi:10.1055/s-0037-1619100

Hämostaseologie, Table of Contents

Hamostaseologie 2010; 30(S 01): S153-S155
DOI: 10.1055/s-0037-1619100

Communication

Schattauer GmbH

Molecular genetic background of haemophilia A patients with discrepancy between one-stage and two-stage factor VIII assays

Authors

A. Pavlova

¹Institute of Experimental Haematology and Transfusion medicine, University Clinic Bonn, Germany
D. Delev

¹Institute of Experimental Haematology and Transfusion medicine, University Clinic Bonn, Germany
S. Pahl

¹Institute of Experimental Haematology and Transfusion medicine, University Clinic Bonn, Germany
J. Driesen

¹Institute of Experimental Haematology and Transfusion medicine, University Clinic Bonn, Germany
H. Brondke

¹Institute of Experimental Haematology and Transfusion medicine, University Clinic Bonn, Germany
J. Oldenburg

¹Institute of Experimental Haematology and Transfusion medicine, University Clinic Bonn, Germany

Abstract

Full Text

References

References
1 Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple onestage antihemophilic factor assay procedure. J Lab Clin Med 1953; 41: 637-647.
2 Biggs R, Eveling J, Richards G. The assay of antihaemophilic-globulin activity. Br J Haematol 1955; 01: 20-34.
3 Seghatchian MJ, Miller-Andersson M. A colorimetric evaluation on factor VIII:C potency. Med Lab Sci 1978; 35: 347-354.
4 Parquet-Gernez A, Mazurier C, Goudemand M. Functional and immunological assays of FVIII in 133 haemophiliacs - characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thromb Haemost 1988; 59: 202-206.
5 Rudzki Z, Duncan EM, Casey GJ. et al. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol 1996; 94: 400-406.
6 Keeling DM, Sukhu K, Kemball-Cook G. et al. Diagnostic importance of the two stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His1954 Leu in theFactor VIIIA3domain. Br J Haematol 1999; 105: 1123-1126.
7 Schwaab R, Oldenburg J, Kemball-Cook G. et al. Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. Br J Haematol 2000; 109: 523-528.
8 Hakeos WH, Miao H, Sirachainan N. et al. Hemophilia A mutations within the factor VIII A2-A3 subunit destabilize factor VIIIa and cause onestage/two-stage activity discrepancy. Thromb Haemost 2002; 88: 781-787.
9 Pipe SW, Saenko EL, Eickhorst AN. et al. Haemophilia A mutations associated with 1-stage/ 2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 2001; 97: 685-691.
10 Macfarlane DE, Stibbe J, Kirby EP. et al. Letter:A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-308.
11 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
12 Pavlova A, Förster T, Detlev D. et al. Heterozygous large deletions of factor 8 gene in females identified by multiplex PCR-LC. Haemophilia 2008; 14: 599-606.